European Heart Journal Advance Access originally published online on March 8, 2007
European Heart Journal 2007 28(7):788-797; doi:10.1093/eurheartj/ehl501
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Division of Cardiovascular Disease and Department of Internal Medicine, Mayo Clinic and College of Medicine, 200 First Street SW, Rochester, MN 55902, USA
Received 10 October 2006; revised 19 December 2006; accepted 4 January 2007; online publish-ahead-of-print 8 March 2007.
* Corresponding author. Tel: +1 507 255 4152; fax: +1 507 255 2550. E-mail address: lerman.amir{at}mayo.edu
Aims: Despite advancements over the past years, normal reperfusion at the myocardial level is not achieved in approximately every other patient with ST-elevation myocardial infarction. In the current work, we aimed at reviewing the role of the coronary microcirculation in the development and outcome of this acute coronary syndrome entity.
Methods and results: A PubMed/Medline search was performed with the key words acute coronary syndrome, acute myocardial infarction, coronary artery disease, endothelial dysfunction, microcirculation, and reperfusion. The synthesis of the information points to myocardial microcirculatory dysfunction as a consequence of a primary epicardial event, based on the vulnerable plaque concept. As an alternative theory, microcirculatory dysfunction may contribute to the clinical course of the acute coronary event, based on the vulnerable patient concept. The pros and cons of these two viewpoints are to be discussed and their influence on patient management is to be considered.
Conclusion: Microcirculatory dysfunction in ST-elevation myocardial infarction can be cause, consequence or both according to non-traditional and traditional concepts.
Key Words: Acute coronary syndrome Myocardial infarction Endothelium Microcirculation
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Rubinshtein, E. H. Yang, C. S. Rihal, A. Prasad, R. J. Lennon, P. J. Best, L. O. Lerman, and A. Lerman Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score Eur. Heart J., November 5, 2009; (2009) ehp459v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Escaned, A. Flores, P. Garcia-Pavia, J. Segovia, J. Jimenez, P. Aragoncillo, C. Salas, F. Alfonso, R. Hernandez, D. J. Angiolillo, et al. Assessment of Microcirculatory Remodeling With Intracoronary Flow Velocity and Pressure Measurements: Validation With Endomyocardial Sampling in Cardiac Allografts Circulation, October 20, 2009; 120(16): 1561 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Barletta, S. Del Pace, M. Boddi, R. Del Bene, C. Salvadori, B. Bellandi, M. Coppo, E. Saletti, and G. F. Gensini Abnormal coronary reserve and left ventricular wall motion during cold pressor test in patients with previous left ventricular ballooning syndrome Eur. Heart J., August 21, 2009; (2009) ehp325v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Shishehbor, S. Madhwal, V. Rajagopal, A. Hsu, P. Kelly, H. S. Gurm, S. R. Kapadia, M. S. Lauer, and E. J. Topol Impact of Blood Transfusion on Short- and Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
J H Bae, T-G Kwon, D-W Hyun, C S Rihal, and A Lerman Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study Heart, December 1, 2008; 94(12): 1559 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schachinger, A. Aicher, N. Dobert, R. Rover, J. Diener, S. Fichtlscherer, B. Assmus, F. H. Seeger, C. Menzel, W. Brenner, et al. Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium Circulation, September 30, 2008; 118(14): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, D. Kivelitz, et al. Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial Circulation, July 1, 2008; 118(1): 49 - 57. [Abstract] [Full Text] [PDF] |
||||



